Physician profile
Kevin E Crowe
NPI 1164404331
$902.42
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $763 · 2020: $113 · 2021: $26.38.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $162.05 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $147.67 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $132.80 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $100.49 | 2019 | |
| Pfizer INC. | $69.62 | 2019-2020 | |
| Amgen INC. | $56.91 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $56.15 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.81 | 2019 | |
| Mylan Specialty L.P. | $25.88 | 2019-2020 | |
| Cardinal Health 200 LLC | $19.50 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $18.49 | 2019 | |
| Ge Healthcare | $18.16 | 2019 | |
| Silk Road Medical, INC. | $16.36 | 2019 | |
| Bard Peripheral Vascular, INC. | $15.15 | 2019 | |
| Cook Medical LLC | $13.65 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $6.73 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Crowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.